Showing results (291-300 of 322) with videos related to
Sort By:
Pageof 33
Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Studies on the biological effects of ozone: 5. Evaluation of immunological parameters and tolerability in normal volunteers receiving ambulatory autohaemotherapyV Bocci, E Luzzi, F Corradeschi, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Restoration of the acute phase response after infection in cyclophosphamide-treated mice by granulocyte colony-stimulating factorM Sawaki, E Kita, K Mikasa, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
The effect of combination therapy of radiation and Z-100, an arabinomannan on tumor growth in miceY Hayashi, H Sasaki, Y Emori, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
Histological analysis of IL-2 induced regression of murine solid SL2-tumorsR A Maas, H F Dullens, D Henk, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Combined treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin plus irradiation. Combined treatment of autoimmune MRL/l miceJ L Fan, K Himeno, A Hussain, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1989
The therapeutic potential of interleukin-1 beta in the treatment of chemotherapy- or radiation-induced myelosuppression and in tumor therapyS Nakai, Y HiraiBiotherapy (Dordrecht, Netherlands)|January 1, 1991
Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resectionT Kondo, J Sakamoto, H NakazatoBiotherapy (Dordrecht, Netherlands)|January 1, 1991
Antitumor action of an acidic glycoprotein (SAGP) from Streptococcus pyogenes in miceJ Yoshida, S Takamura, S SuzukiBiotherapy (Dordrecht, Netherlands)|January 1, 1991
A possible clinical application of multicytokine-producing cytotoxic mononuclear cell (MCCM) therapyM Katano, E Kubota, H Yamamoto, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Development of immunotherapeutic strategies for the treatment of malignant neoplasmsJ E TalmadgePageof 33